
Wilbact S 500mg/500mg Injection
Marketer
Nuwill Biotech Pvt Ltd
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Wilbact S 500mg/500mg Injection
Combiflox 500mg/500mg Injection is a dual-action antibiotic, indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance. Complete the prescribed regimen; premature cessation can reduce efficacy. Missed doses should be avoided. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, edema, respiratory distress). Inform your physician about all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, a balanced diet, and sufficient hydration contribute to optimal recovery. Your doctor may order tests to monitor the treatment's impact.
Uses of Wilbact S 500mg/500mg Injection
Managing Bacterial Infections
Major Benefits of Wilbact S 500mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Wilbact S 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Wilbact S 500mg/500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
How Wilbact S 500mg/500mg Injection works:
Wilbact S 500mg/500mg injection combines the antibiotic cefoperazone with the beta-lactamase inhibitor sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting cefoperazone's antibacterial efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Wilbact S 500mg/500mg Injection treatment can result in adverse effects including facial redness, tachycardia, queasiness, dehydration, pectoral pain, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Wilbact S 500mg/500mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Wilbact S 500mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Wilbact S 500mg/500mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Wilbact S 500mg/500mg Injection's use in patients suffering from renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Wilbact S 500mg/500mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Wilbact S 500mg/500mg Injection :
Omitting a scheduled dose of Wilbact S 500mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Wilbact S 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
